Acalisib Uses, Dosage, Side Effects and more
Acalisib is under investigation in clinical trial NCT01705847 (A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies).
| Trade Name | Acalisib |
| Generic | Acalisib |
| Acalisib Other Names | Acalisib |
| Type | |
| Formula | C21H16FN7O |
| Weight | Average: 401.405 Monoisotopic: 401.140036326 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
